A recent study suggested that miR-128-1 was downregulated in GBM and glioma stem-like cells (GSCs) and miR-128-1 could inhibit the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3 [21]. The gene discussed is BMI1; the disease is central nervous system cancer.